ZEVEX INTERNATIONAL INC
10-Q/A, 1997-10-31
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: FIRST TRUST COMBINED SERIES 33, 485BPOS, 1997-10-31
Next: ZEVEX INTERNATIONAL INC, DEF 14C, 1997-10-31



              Page 1 of 12 consecutively numbered pages
                                  
                              FORM 10-Q

                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C.  20549
(Mark One)
[ X ]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                     SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1996

                                 OR

[   ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from .................to.................

Commission file number 33-19583

                      ZEVEX INTERNATIONAL, INC.
         (Exact name of registrant as specified in charter)

            NEVADA                                                87-0462807
(State or other jurisdiction of                              (I.R.S.Employer
incorporation or organization)                             Identification No.)

5175 Greenpine Drive, Murray, Utah 84123
(Address of principal executive offices)
(Zip Code)84123


                           (801) 264-1001
        (Registrant's telephone number, including area code)

                                           Not Applicable
(Former name, former address, and former fiscal year, if changed since
last report)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes  [ X ] No

          APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
             PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a
plan confirmed by a court.
Yes  [   ]    No  [   ]    Not Applicable  [ X ]
                APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.  As of November 4,
1996, the Company had outstanding 1,495,716 shares of common stock, par
value $0.04 per share.



                             PART I

                      FINANCIAL INFORMATION

______________________________________________________________________

       ITEM 1.  FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q
______________________________________________________________________

ZEVEX International, Inc. (the "Company"), files herewith balance
sheets of the Company as of September 30, 1996, and December 31, 1995,
and the related statements of operations and cash flows for the
respective three month and nine month periods ended September 30, 1996
and 1995.  In the opinion of the Companys management, the financial
statements reflect all adjustments, all of which are normal recurring
adjustments, necessary to fairly present the financial condition of
the Company for the interim periods presented.  The financial
statements included in this report on Form 10-Q should be read in
conjunction with the audited financial statements of the Company and
the notes thereto included in the annual report of the Company on Form
10-KSB for the year ended December 31, 1995.





             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                          Balance Sheet
                           -Unaudited-
                             ASSETS
                                         Sept 30            Dec 31
                                                              
                                          1996              1995
CURRENT ASSETS
         Cash in                         473,748           870,333
           Banks
        Accounts Receivable             862,935          1,209,794
        Employee Advances                 4,022              2,835
        Prepaid Taxes                    52,353                  0
        Work-In-                                                  
         Process                      1,456,740            791,960
                                                                  
           Total Current Assets       2,849,798          2,874,922
OTHER ASSETS
        Net Property & Equipment         637,037           363,771
        Deposits                           3,490             8,682             
                                                                  
 Total Other Assets                      640,527           372,453
            TOTAL ASSETS               3,490,325         3,247,375        
                                
               LIABILITIES & STOCKHOLDERS' EQUITY
LIABILITIES
        Accounts Payable                 344,604           191,562
        Other Accrued Expenses           102,138            96,206
        Income Taxes Payable                   0            58,735
                                                                  
           Total Current Liabilities     446,742           346,503
        Long-Term Debt                         0                 0
        Deferred Taxes                         0                 0             
              Total Long-Term Debt             0                 0             
                                                                  
STOCKHOLDERS EQUITY
       Common Stock 5,000,000                                                  
       shares authorized at $.04 par
       value issued and outstanding
       1,130,716 shares in 1995 and
       1,356,716 share in 1996            54,629            54,629
      Capital in excess of Par Value   1,344,833         1,344,833
      Retained Earnings                1,644,121         1,501,410             
      Total Stockholders Equity        3,043,583         2,900,872             
             TOTAL LIABILITIES &
             STOCKHOLDERS EQUITY       3,490,325         3,247,375
                     






                    ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                         Statement of Operations


                  For Three    For Three    For Nine     For Nine
                   Months       Months       Months       Months
                    Ended        Ended        Ended        Ended
                   9/30/96      9/30/95      9/30/96      9/30/95
REVENUES                                                           
Sales              1,333,030    1,380,141    3,878,255    3,770,055
Cost of Sales                                                      
                     732,085      785,963    2,121,740    2,143,555
                                                                   
Gross Profit         600,945      594,178    1,756,515    1,626,500
                                                                   
General                                                            
Expenses
 Marketing, G&A      382,970      336,031    1,214,623      950,964
 Research   and                                                    
 Devel.              114,521      120,088      360,335      400,579
                                                                   
Operating                         138,059      181,557      274,958
Income               103,454
Other Income           8,078        9,482       35,804       28,127
                                                                   
Provision for    
Taxes               (58,369)      (59,811)    (74,651)      (81,507)
                                                                   
Net Income                                                    
(Loss)                53,163       87,730      142,710      221,577
                                                                   
Income Per                                                   
Share                  .0389        .0644        .1045        .1729
                                                                   
                                                                   
Weighted                                                           
Average Shares                                                     
Outstanding        1,365,716    1,356,716    1,365,716    1,281,347





             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                                
                     Statement of Cash Flows
                                
          For the nine months ended September 30, 1996
                     and September 30, 1995

                                             Sept 30   Sept 30
                                                           
                                               1996      1995
Cash Flows from Operating Activities:                          
                                                               
Net income (loss)                             142,710   221,577
                                                               
Noncash revenue and expense adjustments:                       
   Depreciation                               156,570    98,616
                                                               
Change in assets and liability accounts:                       
(Increase)   decrease   in   accounts        
receivable                                    346,859  (157,233)
(Increase) decrease in work-in-process       (664,780)  (94,968)
   (Increase) decrease in deposits              5,192    (5,000)
   (Increase) decrease in prepaid expenses    (52,353)   16,235
   (Increase) decrease in employee advances    (1,187)        0
   (Increase) decrease in tax refunds               0   109,251
   Increase (decrease) in accounts payable    153,042    36,220
   Increase (decrease) in accrued expenses      5,932    (1,368)               
   Increase  (decrease) in  provision  for               
   taxes                                      (58,735)    32,387
                                                               
Net Cash flows used for                                        
   operating activities                                        
                                               33,250   255,717
                                                               
Cash flows from investing activities:                          
   Purchase of equipment and tooling          (429,835) (159,143)
                                                               
Net increase (decrease) in cash               (396,585)   96,574
                                                               
Cash at beginning of period                                    
                                              870,333   864,332
                                                               
Cash at end of period                                          
                                              473,748   960,906






            ZEVEX INTERNATIONAL, INC. AND SUBSIDIARY
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                
                       September 30, 1996
                                
                                
1. Summary of Significant Accounting Policies

A. Business Information

     The Company was incorporated under the laws of the State of
     Nevada on December 30, 1987.  The Company was originally
     incorporated as Downey Industries, Inc., and changed its
     name to ZEVEX International, Inc., on August 15, 1988.

B. Principles of Consolidation

     The consolidated financial statements include the accounts of
     ZEVEX, International, Inc. (Company) and its wholly-owned
     subsidiary ZEVEX, Inc.  All significant inter-company balances
     and transactions have been eliminated in the consolidation.
     
C. Machinery and Equipment

     Machinery and equipment are stated at cost less accumulated
     depreciation.  Depreciation is provided over expected useful
     lives of five or seven years on accelerated methods, which
     provide for more depreciation expense in the early years of the
     estimated life of the asset.
     
     Major replacements which extend the useful lives of equipment are
     capitalized and depreciated over the remaining useful life.
     Normal maintenance and repair items are charged to costs and
     expenses incurred.
     
     Upon retirement or disposal of property, plant or equipment, the
     costs and related accumulated depreciation amounts are
     eliminated, and any gain or loss is included in operation in the
     year of disposition.
     
Notes to the financial statements - continued

D. Work In Process

     Work in process is stated at the lower of cost (first-in, first-
     out method) or market value.

E. Bad Debts

     The Company accounts for bad debts using the direct write off
     method.  Accounts are written off when deemed uncollectible.
     
F. Net Income Per Share

     The computation of net income per share of common stock is
     computed  by dividing net income for the period by the weighted
     average number of shares outstanding during the period.  Common
     stock equivalents which dilute earnings per share are not taken
     into consideration in the calculation because they have no
     material impact.

2. Business Combination

On August 11, 1988, the Company acquired the outstanding stock of
ZEVEX, Inc., a manufacturer and producer of acoustic and electronic
equipment for special applications, in exchange for 600,000 shares of
its common stock.  This business combination has been accounted for in
a manner similar to a pooling-of-interests.

Notes to the financial statements - continued

3. Income Taxes

Provision for income taxes is made, at Federal and State statutory
rates, based on earnings reported in the financial statements for the
amount of income taxes payable currently, less any prepayment
deposits.  The provision for income taxes at September 30, 1996 and
September 30, 1995 consists of the following:
                                             1996          1995

Federal income taxes                       $  63,783     $  24,054
State income taxes                            10,868         8,333
Provision for income tax                  $   74,651     $  32,387
==========    ==========

4.Major Customers

The Company distributes its products directly and is not dependent
upon any single customer.  However, sales to three customers for the
nine months ending September 30, 1996, each represented 10% or more of
total sales.
______________________________________________________________________

        ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS
______________________________________________________________________

Results of Operations

The Company's sales decreased to $1,333,030 in the third quarter 1996
from $1,380,141 in the third quarter 1995, and increased to $3,878,255
for the first nine months of 1996, from $3,770,055 for the first nine
months of 1995, a decrease of approximately 4% for the three months
ending September 1996, and an increase of 3% for the nine months
ending September 1996.  During the first nine months of 1996, 63% of
total revenues resulted from sales to three customers, all of whom
were major customers in 1995.  Since most of the Company's products
are sold to OEMs as components for incorporation into products
manufactured by them, demand for the Company's products is affected by
the demand for the final products manufactured by the OEMs, which is
beyond the control of the Company, and no assurances can be given that
orders from any customer will increase or remain at current levels or
that they will not decline.

The Company's gross profit as a percentage of sales was 45% in the
third quarter 1996, as compared to 43% in the third quarter 1995, and
45% for the nine months ending September 1996 compared to 43% for the
nine months ending September 1995.  Management attributes the increase
to the product mix that was delivered during these periods of 1996.

Selling, general and administrative expenses for the quarter ended
September 30, 1996 increased $46,939, from $336,031 in the second
quarter of 1995 to $382,970 in the third quarter of 1996.  Management
attributes the increase in these expenses to increased sales effort,
including travel, and legal costs related to the introduction and
marketing trials of the new Enteralite(Trademark) ambulatory enteral
feeding pump, and increased expenses related to employee insurance and
tax costs.  The Company believes that general and administrative
expenses will remain constant for the remainder of 1996.

Research and development expenses vary from quarter to quarter
depending on the number and nature of pending research and development
projects and their various stages of completion.  During the third
quarter of 1996, research and development expenses were $114,521
compared to $120,088 during the third quarter of 1995, and $360,335
for the first nine months of 1996, compared to $400,579 for the first
nine months of 1995.  Expenses incurred during the first nine months
were for the continued development of several proprietary products and
new applications of the company's ultrasound technology.  Management
believes investing in research and development will serve the
company's future well, and will continue these expenses at the current
rate for at least the next several quarters.

Net income decreased to $53,163, or 4% of net sales, in the third
quarter of 1996, from $87,730 in the third quarter of 1995.  Net
income of $142,710, or 3.7% of net sales, for the first nine
months of 1996 decreased from a net income of $221,577 in the
first nine months of 1995.  The decreases in net income during
1996 as compared to 1995 are principally due to increased
selling, general and administrative expenses for the current
year, and a change in the tax law regarding research and
development tax credit.

As of September 30, 1996 the Company's backlog of customer orders was
$4,357,000, as compared to $3,688,000 on September 30, 1995.
Management estimates that approximately 40% of the backlog will ship
before December 31, 1996.

Liquidity and Capital Resources

During the quarter ending September 30, 1996, and the nine months
ending September 30 1996, the Company produced $53,163 in net income
and $142,710 in net income respectively from operating activities.
Cash decreased by $396,585 for the nine months ending September 30,
1996 as the company funded an increase in inventories and work in
process, as well as major production tooling costs.  During the
quarter ending September 30, 1995, and the nine months ending
September 30 1995, the Company had net incomes of $87,730 and $221,577
respectively from operating activities. Net cash increased by $96,574
for the nine months ending September 30, 1995, as the Company funded
an increase in accounts receivable and inventories of work in progress
for future sale.

The Company's purchases of new research, production, test equipment
and tooling was $59,288 for the third quarter of 1996, and $429,835
for the first nine months of 1996.  The Company has no material
commitments for the purchase of equipment or tooling during the
remainder of 1996.

The Company's working capital at September 30, 1996, was $2,403,056 as
compared to $2,423,994 at September 30, 1995.  The decrease is
primarily attributed to a decrease in income from operations.  The
portion of working capital represented by cash at such dates was
$473,748 and $960,906 respectively.  The Company utilizes substantial
portions of its cash from time to time to fund its operations.

On October 30, 1996, the company completed the issuance and sale of a
$2,000,000 aggregate principal amount of adjustable rate Industrial
Development Revenue Bonds, series 1996 (ZEVEX, Inc., Project) of
Murray City, Salt Lake County, Utah.  The bonds will finance
construction of a manufacturing facility for the Company in Murray,
Utah.

On October 29, 1996, the Company completed a transaction for the
amount of $50,000 cash and 130,000 shares of unregistered stock of the
company for the purchase of approximately 3.7 acres of land within
Murray City, Salt Lake County, Utah, for the purpose of constructing a
manufacturing facility with an unrelated party.  As a result of the
above transactions, stockholders equity increased $455,000 subsequent
to the September 30, 1996, balance sheet date.  Also, assets and
liabilities of the company will increase by approximately $2,000,000
subsequent to the September 30, 1996, balance sheet date.

The Companys warrants, issued on April 29, 1993, expired on October
29, 1996.  The exercise price on the warrants was $6.67.  The warrants
could not be exercised in the absence of an effective registration
statement.  The Company chose not to extend the expiration date of the
warrants, because the current common stock price was $3.25, had never
been near the exercise price, and would not be exercisable in the
foreseeable future.


                             PART II

Item 6.  Item 10. Material Contracts
                  Offering Memorandum "$2,000,000 Murray City, Utah
                  Adjustable Rate Industrial Development Bonds, Series
                  1996 (ZEVEX, INC. PROJECT)
         Item 10. Reimbursement Agreement


          OTHER INFORMATION NOT APPLICABLE AT THIS TIME

Item 1.  Legal Proceedings
Item 2.  Changes in Securities
Item 3.  Defaults upon Senior Securities
Item 4.  Submission of Matters to a Vote of Security Holders
Item 5.  Other Information



______________________________________________________________________

                           SIGNATURES
______________________________________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.


ZEVEX INTERNATIONAL, INC.


Dated:  November 4, 1996              By   /s/ Dean G. Constantine
Dean G. Constantine, President


                                      By   /s/ Phillip L. Mcstotts
                                        Phillip L. McStotts, Secretary
                                         (Principal Financial Officer)


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                         473,748
<SECURITIES>                                         0
<RECEIVABLES>                                  862,935
<ALLOWANCES>                                         0
<INVENTORY>                                    664,780
<CURRENT-ASSETS>                             2,849,798
<PP&E>                                       1,253,821
<DEPRECIATION>                                 616,784
<TOTAL-ASSETS>                               3,490,325
<CURRENT-LIABILITIES>                          446,742
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        54,629
<OTHER-SE>                                   2,988,954
<TOTAL-LIABILITY-AND-EQUITY>                 3,490,325
<SALES>                                      1,333,030
<TOTAL-REVENUES>                             1,333,030
<CGS>                                          732,085
<TOTAL-COSTS>                                  732,085
<OTHER-EXPENSES>                               497,491
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                111,532
<INCOME-TAX>                                    58,369
<INCOME-CONTINUING>                             53,163
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    53,163
<EPS-PRIMARY>                                     .039
<EPS-DILUTED>                                     .039
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission